A 50 bp deletion in the SOD1 promoter lowers enzyme expression but is not associated with ALS in Sweden

References

• Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59–62.
   PubMed Web of Science ®Google Scholar
• Andersen PM. Amyotrophic Lateral Sclerosis and CuZn-Superoxid Dismutase. Thesis. 1997.
   Google Scholar
• Cudkowicz ME, McKenna-Yasek D, Sapp PE, Chin W, Geller B, Hayden DL, et al. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Annals of Neurology. 1997;41:210–21.
   PubMed Web of Science ®Google Scholar
• Millecamps S, Salachas F, Cazeneuve C, Gordon P, Bricka B, Camuzat A, et al. SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. Journal of Medical Genetics. 2010;47:554–60.
   PubMed Web of Science ®Google Scholar
• Chio A, Traynor BJ, Lombardo F, Fimognari M, Calvo A, Ghiglione P, et al. Prevalence of SOD1 mutations in the Italian ALS population. Neurology. 2008;70:533–7.
   PubMed Web of Science ®Google Scholar
• Andersen PM, Nilsson P, Ala-Hurula V, Keranen M, Tarvainen I, Haltia T, et al. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in Cu/Zn superoxide dismutase. Nat Genet. 1995;10:61–6.
   PubMed Web of Science ®Google Scholar
• Brotherton T, Polak M, Kelly C, Birve A, Andersen PM, Marklund SL, et al. A novel ALS SOD1 C6S mutation with implications for aggregation related toxicity and genetic counselling. Amyotroph Lateral Scler. 2011;12:215–9.
   PubMed Web of Science ®Google Scholar
• Synofzik M, Ronchi D, Keskin I, Basak AN, Wilhelm C, Gobbi C, et al. Mutant superoxide dismutase-1 indistinguishable from wild-type causes ALS. Human Molecular Genetics. 2012;21:3568–74.
   PubMed Web of Science ®Google Scholar
• Forsberg K, Jonsson PA, Andersen PM, Bergemalm D, Graffmo KS, Hultdin M, et al. Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PloS One. 2010;5:e11552.
   PubMed Web of Science ®Google Scholar
• Bosco DA, Morfini G, Karabacak NM, Song Y, Gros-Louis F, Pasinelli P, et al. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nature Neuroscience. 2010;13:1396–403.
   PubMed Web of Science ®Google Scholar
• Forsberg K, Andersen PM, Marklund SL, Brännström. Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis. Acta Neuropathologica. 2011;121:623–34.
   PubMed Web of Science ®Google Scholar
• Graffmo KS, Forsberg K, Bergh J, Birve A, Zetterstrom P, Andersen PM, et al. Expression of wild-type human superoxide dismutase-1 in mice causes amyotrophic lateral sclerosis. Human Molecular Genetics. 2013;22:51–60.
   PubMed Web of Science ®Google Scholar
• Broom WJ, Parton MJ, Vance CA, Russ C, Andersen PM, Hansen V, et al. No association of the SOD1 locus and disease susceptibility or phenotype in sporadic ALS. Neurology. 2004;63:2419–22.
   PubMed Web of Science ®Google Scholar
• Broom W, Greenway M, Sadri-Vakili G, Russ C, Auwarter K, Glajch K, et al. 50 bp deletion in the promoter for superoxide dismutase 1 (SOD1) reduces SOD1 expression in vitro and may correlate with increased age of onset of sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2008;9:229–37.
   PubMed Web of Science ®Google Scholar
• Milani P, Gagliardi S, Bongioanni P, Grieco GS, Dezza M, Bianchi M, et al. Effect of the 50 bp deletion polymorphism in the SOD1 promoter on SOD1 mRNA levels in Italian ALS patients. Journal of the Neurological Sciences. 2012;313:75–8.
   PubMed Web of Science ®Google Scholar
• de Roy P. Helsinki and the Declaration of Helsinki. World Med J. 2004;50:9–11.
   Google Scholar
• Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, van Damme P, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS): revised report of an EFNS task force. Eur J Neurol. 2012;19:360–75.
   PubMed Web of Science ®Google Scholar
• Byrne S, Bede P, Elamin M, Kenna K, Lynch C, McLaughlin R, et al. Proposed criteria for familial amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis: official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2011;12:157–9.
   PubMed Web of Science ®Google Scholar
• Freischmidt A, Wieland T, Richter B, Ruf W, Schaeffer V, Muller K, et el. Haploinsufficiency of TBK1 causes familial ALS and frontotemporal dementia. Nature Neuroscience. 2015;18:631–6.
   PubMed Web of Science ®Google Scholar
• Akimoto C, Volk AE, van Bitterswijk M, van den Broeck M, Leblond CS, Lumbroso S, et al. A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories. J Med Genet. 2014;51:419–24.
   PubMed Web of Science ®Google Scholar
• Marklund S. Spectrophotometric study of spontaneous disproportionation of superoxide anion radical and sensitive direct assay for superoxide dismutase. The Journal of Biological Chemistry. 1976;251:7504–7.
   PubMed Web of Science ®Google Scholar
• Marklund SL, Andersen PM, Forsgren L, Nilsson P, Ohlsson PI, Wikander G, et al. Normal binding and reactivity of copper in mutant superoxide dismutase isolated from amyotrophic lateral sclerosis patients. J Neurochem. 1997;69:675–81.
   PubMed Web of Science ®Google Scholar
• Andersen PM, Nilsson P, Forsgren L, Marklund SL. Cu/Zn superoxide dismutase, extracellular superoxide dismutase, and glutathione peroxidase in blood from individuals homozygous for Asp90Ala Cu/Zu superoxide dismutase mutation. J Neurochem. 1998;70:715–20.
   PubMed Web of Science ®Google Scholar
• Milani P, Gagliardi S, Cova E, Cereda C. SOD1 Transcriptional and Post-transcriptional Regulation and Its Potential Implications in ALS. Neurology Research International. 2011;2011:458427.
   PubMedGoogle Scholar
• Seo SJ, Kim HT, Cho G, Rho HM, Jung G. Sp1 and C/EBP-related factor regulates the transcription of human Cu/Zn SOD gene. Gene. 1996;178:177–85.
   PubMed Web of Science ®Google Scholar
• Majoor-Krakauer D, Willems PJ, Hofman A. Genetic epidemiology of amyotrophic lateral sclerosis. Clinical Genetics. 2003;63:83–101.
   PubMed Web of Science ®Google Scholar
• Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain.: a journal of neurology. 1995;118:707–19.
   Google Scholar